Zobrazeno 1 - 10
of 166
pro vyhledávání: '"Johannes M. Giesinger"'
Autor:
Micha J. Pilz, Fanny L.C. Loth, Sandra Nolte, Anna M.M. Thurner, Eva-Maria Gamper, Amélie Anota, Gregor Liegl, Johannes M. Giesinger, on behalf of the EORTC Quality of Life Group
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-10 (2024)
Abstract Background General population normative values for the widely used health-related quality of life (HRQoL) measure EORTC QLQ-C30 support the interpretation of trial results and HRQoL of patients in clinical practice. Here, we provide sex-, ag
Externí odkaz:
https://doaj.org/article/9a32ec4a91b5485c956b5b9e626c6bbd
Autor:
Fabio Efficace, Rena Buckstein, Gregory A. Abel, Johannes M. Giesinger, Pierre Fenaux, Jan Philipp Bewersdorf, Andrew M. Brunner, Rafael Bejar, Uma Borate, Amy E. DeZern, Peter Greenberg, Gail J. Roboz, Michael R. Savona, Francesco Sparano, Jacqueline Boultwood, Rami Komrokji, David A. Sallman, Zhuoer Xie, Guillermo Sanz, Hetty E. Carraway, Justin Taylor, Stephen D. Nimer, Matteo Giovanni Della Porta, Valeria Santini, Maximilian Stahl, Uwe Platzbecker, Mikkael A. Sekeres, Amer M. Zeidan
Publikováno v:
HemaSphere, Vol 8, Iss 5, Pp n/a-n/a (2024)
Abstract Notable treatment advances have been made in recent years for patients with myelodysplastic syndromes/neoplasms (MDS), and several new drugs are under development. For example, the emerging availability of oral MDS therapies holds the promis
Externí odkaz:
https://doaj.org/article/cf17fd5c0de047b1a6c103df622ef528
Autor:
Fabio Efficace, Wael Al Essa, Uwe Platzbecker, Pasquale Niscola, Giuseppe A. Palumbo, Giovanni Caocci, Francesco Cottone, Massimo Breccia, Mario Luppi, Reinhard Stauder, Alessandra Ricco, Duska Petranovic, Frederic Baron, Maria Teresa Voso, Luana Fianchi, Chiara Frairia, Isabella Capodanno, Chiara Sarlo, Marilena Fedele, Roberto Massimo Lemoli, Rosangela Invernizzi, Daniele Vallisa, Nicola Di Renzo, Claudio Fozza, Maribel Doro, Johannes M. Giesinger, Marco Vignetti
Publikováno v:
HemaSphere, Vol 7, Iss 9, p e944 (2023)
Health-related quality of life (HRQoL) is an important goal of therapy for patients with myelodysplastic syndromes (MDS); however, little is known about HRQoL of these patients at clinical presentation. We report HRQoL profile of newly diagnosed pati
Externí odkaz:
https://doaj.org/article/e1521fb1a8594782b9707be424ba91a2
Autor:
Micha J. Pilz, Eva-Maria Gamper, Fabio Efficace, Juan I. Arraras, Sandra Nolte, Gregor Liegl, Matthias Rose, Johannes M. Giesinger, on behalf of the EORTC Quality of Life Group
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background General population normative values for the widely used health-related quality of life (HRQoL) measure, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire – Core 30 (EORTC QLQ-C30), are avai
Externí odkaz:
https://doaj.org/article/55558b85c21645bb8170f4da242a0206
Autor:
Jens Lehmann, Isabel Schreyer, David Riedl, Michael Tschuggnall, Johannes M. Giesinger, Marjiana Ninkovic, Marcus Huth, Irmgard Kronberger, Gerhard Rumpold, Bernhard Holzner
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Faecal incontinence (FI) is prevalent in 15–20% of elderly individuals and is frequently monitored in clinical trials and practice. Bowel diaries are the most common way to document FI, but, in clinical practice, are mainly used
Externí odkaz:
https://doaj.org/article/826113f6c10b413bb4a1a12f99835333
Autor:
Fabio Efficace, Laura Cannella, Francesco Sparano, Johannes M. Giesinger, Marco Vignetti, Frédéric Baron, Eduardo Bruera, Mario Luppi, Uwe Platzbecker
Publikováno v:
HemaSphere, Vol 6, Iss 12, p e802 (2022)
The inclusion of patient-reported outcome (PRO) measures in chimeric antigen receptor (CAR) T-cell therapy research is critical for understanding the impact of this novel approach from a unique patient standpoint. We performed a scoping review to map
Externí odkaz:
https://doaj.org/article/b11d42d44cfe4eefa72e173efd8fc36f
Autor:
Juan Ignacio Arraras, Sandra Nolte, Gregor Liegl, Matthias Rose, Ana Manterola, Jose Juan Illarramendi, Uxue Zarandona, Mikel Rico, Lucia Teiejria, Gemma Asin, Irene Hernandez, Marta Barrado, Ruth Vera, Fabio Efficace, Johannes M. Giesinger, the EORTC Quality of Life Group
Publikováno v:
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-12 (2021)
Abstract Purpose General population normative data for the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire facilitates interpretation of data assessed from cancer patients. This study aims to present normative
Externí odkaz:
https://doaj.org/article/73fe622a78054b528912fd99241cce4c
Autor:
Jens Lehmann, Bernhard Holzner, Johannes M. Giesinger, Andrew Bottomley, Shaad Ansari, Ludwig von Butler, Georg Kemmler
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background The impact of the coronavirus disease (COVID-19) pandemic on wellbeing and health has so far been studied using mostly cross-sectional designs. To place recent findings into context, we compared symptoms and functional health stat
Externí odkaz:
https://doaj.org/article/8d164ead97c642b7bc577ba7bd1c29d4
Autor:
Lisa M. Wintner, Johannes M. Giesinger, Monika Sztankay, Andrew Bottomley, Bernhard Holzner, on behalf of the EORTC Quality of Life Group
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-7 (2020)
Abstract Background In oncology, detection and tracking of adverse events are of top priority and rely mostly on the Common Terminology Criteria for Adverse Events (CTCAE). Besides, clinical trials use as well patient-reported outcomes (PROs) to asse
Externí odkaz:
https://doaj.org/article/1e18040c2fd24b7e972a95d215e244b0
Autor:
Jens Lehmann, Johannes M. Giesinger, Sandra Nolte, Monika Sztankay, Lisa M. Wintner, Gregor Liegl, Matthias Rose, Bernhard Holzner, on behalf of the EORTC Quality of Life Group
Publikováno v:
Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-9 (2020)
Abstract Background The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 is a widely used cancer-specific questionnaire assessing 15 domains of health-related quality of life (HRQoL). Our aim was to facilitate the interpreta
Externí odkaz:
https://doaj.org/article/b0f7bc6ca9d2418eb7919afee50b61f3